We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

91 hedge funds and large institutions have $406M invested in Calithera Biosciences, Inc in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 26

6% more capital invested

Capital invested by funds: $382M → $406M (+$24M)

3% less funds holding

Funds holding: 94 → 91 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

30% less call options, than puts

Call options by funds: $1.42M | Put options by funds: $2.04M

Holders
91
Holders Change
-3
Holders Change %
-3.19%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
35
Reduced
26
Closed
17
Calls
$1.42M
Puts
$2.04M
Net Calls
-$618K
Net Calls Change
+$1.18M

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
+$7.27M
2
American Century Companies
American Century Companies
Missouri
+$4.9M
3
Millennium Management
Millennium Management
New York
+$3.98M
4
State Street
State Street
Massachusetts
+$3.92M
5
AC
Ascend Capital
California
+$3.86M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.15M
3
BIM
Bogle Investment Management
Massachusetts
-$7.31M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
76
Bank of America
North Carolina
$113K +$38.2K +121 +51%
Macquarie Group
77
Macquarie Group
Australia
$72K +$72.6K +230 New
SO
78
STRS Ohio
Ohio
$56K +$25.2K +80 +80%
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$52K +$1.58K +5 +3%
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$49K +$47.6K +151 +2,157%
AIP
81
Ameritas Investment Partners
Nebraska
$44K – – –
EWM
82
Edge Wealth Management
New York
$28K +$28.4K +90 New
Acadian Asset Management
83
Acadian Asset Management
Massachusetts
$25K -$3.67M -11,619 -99%
FPFS
84
First Personal Financial Services
North Carolina
$21K – – –
PNC Financial Services Group
85
PNC Financial Services Group
Pennsylvania
$16K – – –
IA
86
IFP Advisors
Florida
$3K -$31.5K -100 -91%
TRCT
87
Tower Research Capital (TRC)
New York
$3K -$24K -76 -89%
AWMS
88
Advocacy Wealth Management Services
Georgia
$3K – – –
SPIA
89
Steward Partners Investment Advisory
New York
$3K +$3.15K +10 New
LF
90
Lee Financial
Texas
$2K – – –
MAM
91
Meeder Asset Management
Ohio
$1K +$946 +3 New
EI
92
EAM Investors
California
– -$1.26M -4,233 Closed
SSA
93
Schonfeld Strategic Advisors
New York
– -$1.11M -3,750 Closed
Squarepoint
94
Squarepoint
New York
– -$451K -1,520 Closed
GAMA
95
Graticule Asia Macro Advisors
New York
– -$303K -1,020 Closed
CEP
96
Chicago Equity Partners
Illinois
– -$279K -941 Closed
PP
97
PDT Partners
New York
– -$278K -935 Closed
TC
98
TFS Capital
Pennsylvania
– -$255K -858 Closed
CSS
99
Cubist Systematic Strategies
Connecticut
– -$222K -749 Closed
HCM
100
Howland Capital Management
Massachusetts
– -$178K -600 Closed
1 2 3
4
5

CALA Hedge Fund Activity: Q3 2017 in Review

91 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2017, worth a combined $406M — up 6.3% from $382M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CALA and 14 opened new positions — a net loss of 3 holders — while 26 trimmed existing stakes and 35 added.

The largest buyer was AQR Capital Management, adding an estimated $7.27M. The largest seller was Adage Capital Partners, cutting an estimated $10.6M.

  • 91 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2017, down from 94 in Q2 2017.
  • Funds reported $406M of Calithera Biosciences, Inc stock for Q3 2017, up 6.3% quarter-over-quarter.
  • 14 funds opened new Calithera Biosciences, Inc positions in Q3 2017 and 17 closed out, a net change of -3 holders.
  • The largest Calithera Biosciences, Inc buyer in Q3 2017 was AQR Capital Management, an estimated $7.27M added.
  • The largest Calithera Biosciences, Inc seller in Q3 2017 was Adage Capital Partners, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2017.